Chiranjit Deka is an accomplished professional with extensive experience in the medical device and biotechnology fields. Currently serving as the MDSAP Program Manager, Regional Lead Reviewer, and Certificate Decision Maker at UL Solutions since 2018, Chiranjit oversees the Medical Device Single Audit Program, addressing technical, quality, regulatory, commercial, and personnel development needs. Previously, Chiranjit held key leadership roles, including CTO and CEO at Indexus Biomedical LLC, where advanced flow cytometry and hematology technologies were developed, and as Vice President of Product Development at Advanced Liquid Logic, leading to a significant acquisition by Illumina. Chiranjit's career also includes positions at IDEXX Laboratories, Beckman Coulter Life Sciences, and Beckman Coulter Diagnostics, focusing on hematology product development and engineering, with numerous patents in the field. Chiranjit earned a Ph.D. in Physics (Optics and Laser Engineering) from the University of Central Florida and a Master of Science (M.Sc.) in Physics from the University of Windsor.
This person is not in any teams
This person is not in any offices